This is how the creation of vaccines against COVID-19 in Latin America progresses
more than 300 candidates for vaccines against COVID-19 that had been registered all over the planet. Of these, at least twelve had already passed the third clinical phase, for which their use in humans had been approved. As expected, European countries, China and the United States were the ones that took advantage in the race to obtain a vaccine. Biologics such as those from Pfizer (United States), Sinovac (China), AstraZeneca (United Kingdom) and Sputnik V (Russia), have been the most popular worldwide. With its inoculation, the hope of reaching the beginning of the end of the pandemic was ...
Source: latinamericanpost.com